Reshoring generic pharmaceutical production is essential in today’s era of geopolitical instability and heightened awareness ...
Among pediatric patients with intermittent asthma, around one-third did not have significant acute care needs over a 2-year ...
The FDA has approved updated prescribing information for Airsupra to include the BATURA study in patients with mild asthma.
New Scientist on MSN
Two-in-one inhalers slash asthma attacks among young children
Inhalers that combine relieving breathlessness with preventing it seem to be the most effective option for reducing asthma ...
AstraZeneca will launch a new online platform to make Airsupra, as well as Farxiga and Flumist, available for home delivery ...
Novartis said that it is exploring an additional direct-to-employer model to increase access and affordability for ...
AstraZeneca Plc (NASDAQ: AZN) launched AstraZeneca Direct, an online platform designed to create a simple, convenient way for ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
PRIMETIMER on MSN
High Potential Season 2 episode 3 ending explained: Who was behind the attack on Nathan Gould?
The new case for Morgan and the LAPD in High Potential Episode 3 revolved around Nathan Gould, a gambling addict who was attacked because of his heart ...
Asking briefly about signs and symptoms of asthma allows clinicians to find unrecognized cases even in a community with an ...
MedPage Today on MSN
Reliever Combo Inhaler Better Than SABA Alone for Kids' Mild Asthma
As reliever monotherapy for mild asthma, the inhaled corticosteroid (ICS)-formoterol combination reduced asthma attacks in children compared with a short-acting β₂-agonist (SABA), the CARE trial ...
Comic Book Resources on MSN
High Potential Season 2, Episode 3 Raises Ethical Questions
High Potential is back to its typical case-of-the-week format, but the subject matter keeps creeping into Morgan's personal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results